Particularly, the reduction of GLP-1 release over time has been an observed feature of T2DM development, as GLP-1 reduces glucagon secretion and hepatic gluconeogenesis while promoting insulin secretion, thereby effectively minimizing hyperglycemia [106]
3 Losing weight can have positive effects on mood and mental wellbeing, which may complement the effects of your antidepressant medication
Blood pressure and heart rate monitoring Cardiovascular monitoring remains paramount for GLP-1 non-responders transitioning to sympathomimetic agents like phentermine
This makes it difficult for the body to digest these nutrients properly, which can lead to diarrhea
Healthcare providers personalize your semaglutide dose by taking a gradual, responsive approach based on your unique health profile and how your body reacts to the medication
The bottom line on retatrutide in the UK Retatrutide is the most effective obesity medicine yet reported in a Phase 3 trial, and after the July 2026 readouts its evidence base is close to complete